G1 Therapeutics Announces Top Line Results from Pivotal
- PRESERVE 1 Achieved its Co-Primary Endpoints Showing Statistically Significant Reductions in Occurrence of Severe
Globe Newswire13-02-2023, 18:03
RIB Software Cements Carbon Credentials with Groundbreaking 2050 Materials Partnership 20-06-2024, 15:45